3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
1
Conditions
Lung Diseases
2
Respiratory Aspiration
1
Pulmonary Atelectasis
1
Pneumothorax
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Diseases
1
Pericardial Effusion
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Hemothorax
1
Empyema, Pleural
1
Interventions
Cyclophosphamide
2040
Radiotherapy
1854
Cisplatin
1820
Carboplatin
1530
Gemcitabine
1432
Paclitaxel
1289
Bevacizumab
1267
Docetaxel
1200
pembrolizumab
1196
Oxaliplatin
1157
Capecitabine
1140
Fluorouracil
1059
Dexamethasone
971
Rituximab
918
Nivolumab
908
Magnetic Resonance Spectroscopy
858
Etoposide
839
Doxorubicin
823
Drug Therapy
789
Radiosurgery
774
Irinotecan
774
Cytarabine
736
fludarabine
714
Leucovorin
674
Lenalidomide
608
fludarabine phosphate
564
Temozolomide
552
Filgrastim
540
Radiation
539
Cetuximab
535
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
One-Lung Ventilation
×
Clear all
NCT00534690
2026-05-15
REVOLU
University Hospital, Bordeaux
Phase NA
Completed
88 enrolled
NCT05077111
2021-10-14
VATS
Ain Shams University
Phase 4
Unknown
40 enrolled